Evidence map›Paper›PMID 31996174›Full record

ArticleBMC psychiatry2020

Study protocol of a randomised clinical trial testing whether metacognitive training can improve insight and clinical outcomes in schizophrenia.

Javier-David Lopez-Morinigo, Verónica González Ruiz-Ruano, Adela Sánchez Escribano Martínez, María Luisa Barrigón Estévez, Laura Mata-Iturralde, Laura Muñoz-Lorenzo, Sergio Sánchez-Alonso, Antonio Artés-Rodríguez, Anthony S David, Enrique Baca-García

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMC psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04104347 (Does Metacognitive Training Improve Insight and Clinical Outcomes in Schizophrenia?), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04104347 naunknown statusnot on this map

Does Metacognitive Training Improve Insight and Clinical Outcomes in Schizophrenia?

TypeinterventionalSponsorInstituto de Investigación Sanitaria de la Fundación Jiménez DíazRan2019 to 2021Enrolled252ConditionsSchizophrenia Spectrum and Other Psychotic DisordersArmsMetacognitive training (MCT), Support group
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Javier-David Lopez-MorinigoDepartamento de Psiquiatría, IIS-Fundación Jiménez Díaz, Madrid, Spain. javierd.lopez@uam.es.
Verónica González Ruiz-RuanoDepartamento de Psiquiatría, IIS-Fundación Jiménez Díaz, Madrid, Spain.
Adela Sánchez Escribano MartínezDepartamento de Psiquiatría, IIS-Fundación Jiménez Díaz, Madrid, Spain.
María Luisa Barrigón EstévezDepartamento de Psiquiatría, IIS-Fundación Jiménez Díaz, Madrid, Spain.
Laura Mata-IturraldeDepartamento de Psiquiatría, IIS-Fundación Jiménez Díaz, Madrid, Spain.
Laura Muñoz-LorenzoDepartamento de Psiquiatría, IIS-Fundación Jiménez Díaz, Madrid, Spain.
Sergio Sánchez-AlonsoDepartamento de Psiquiatría, IIS-Fundación Jiménez Díaz, Madrid, Spain.
Antonio Artés-RodríguezDepartamento de Teoría de Señal y de la Comunicación, Universidad Carlos III, Madrid, Spain.
Anthony S DavidInstitute of Mental Health, University College London, London, UK.
Enrique Baca-GarcíaDepartamento de Psiquiatría, IIS-Fundación Jiménez Díaz, Madrid, Spain.
Hospital Universitario Fundación Jiménez Díaz · ESCatholic University of the Maule · CLCentro de Salud Casa del Barco · ESInstitute of Mental Health · GBUniversidad Carlos III de Madrid · ES

Funding

Instituto de Salud Carlos III ISCIII PI16/01852Madrid Regional Government (Madrid, Spain) B2017/BMD-3740 AGES-CM 2CM; Y2018/TCS-4705 PRACTICO-CMUniversidad Autónoma de Madrid (Madrid (Spain) and European Commission GA713366
6 · The paper itself

Abstract

backgroundAlthough insight in schizophrenia spectrum disorders (SSD) has been associated with positive outcomes, the effect size of previous treatments on insight has been relatively small to date. The metacognitive basis of insight suggests that metacognitive training (MCT) may improve insight and clinical outcomes in SSD, although this remains to be established.

methodsThis single-center, assessor-blind, parallel-group, randomised clinical trial (RCT) aims to investigate the efficacy of MCT for improving insight (primary outcome), including clinical and cognitive insight, which will be measured by the Schedule for Assessment of Insight (Expanded version) (SAI-E) and the Beck Cognitive Scale (BCIS), respectively, in (at least) n = 126 outpatients with SSD at three points in time: i) at baseline (T0); ii) after treatment (T1) and iii) at 1-year follow-up (T2). SSD patients receiving MCT and controls attending a non-intervention support group will be compared on insight level changes and several clinical and cognitive secondary outcomes at T1 and T2, whilst adjusting for baseline data. Ecological momentary assessment (EMA) will be piloted to assess functioning in a subsample of participants. DISCUSSION: To the best of our knowledge, this will be the first RCT testing the effect of group MCT on multiple insight dimensions (as primary outcome) in a sample of unselected patients with SSD, including several secondary outcomes of clinical relevance, namely symptom severity, functioning, which will also be evaluated with EMA, hospitalizations and suicidal behaviour.

trial registrationClinicalTrials.gov: NCT04104347. Date of registration: 26/09/2019 (Retrospectively registered).

Indexed as

Schizophrenic PsychologyAdolescentAdultChildCognitive Behavioral TherapyFemaleFollow-Up StudiesHumansMaleMetacognitionMiddle AgedRandomized Controlled Trials as TopicSchizophreniaSingle-Blind MethodTreatment OutcomeYoung AdultEcological momentary assessmentInsightMetacognitive trainingSchizophrenia spectrum disorders

Identifiers

PMID31996174
PMCPMC6990523
OpenAlexW3006471746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.